Director Shareholding

GlaxoSmithKline PLC
4 October 2001

                             Directors' Interests



I give below details of changes in directors' interests in the Ordinary Shares
of GlaxoSmithKline plc.


28         The Administrators of the SmithKline Beecham US Retirement Savings
September  Plan ('the Plan') notified GlaxoSmithKline plc on the 4 October 2001,
2001       that as a result of movement in the fund on the 28 September 2001,
           the number of Ordinary Share ADRs held by the fund had increased from
           18,250,080 to 18,440,404 at an average price of $56.1200.

The Plan is a discretionary fund of which all employees or former employees of
SmithKline Beecham plc and its subsidiaries are potential beneficiaries. One
of the Company's directors, Dr J P Garnier is therefore, interested in the
shares held in the fund from time to time in the same way as other employees
or former employees of SmithKline Beecham plc and its subsidiaries.



S M Bicknell

Company Secretary

4 October 2001